The Early Career Bioanalytical Scientists (ECBS) subteam is proud to announce two webinars in our Introduction to DMPK for BA scientists series.
- November 10th 12-1pm EST: Continuation of DMPK concepts by Vibha Jawa (BMS)
- November 17th 12-1pm EST: ADME tests in preclinical studies: Principles, Approaches, challenges, and learnings by Bonnie Wang (BMS) and Jiangbo Tang (BMS).
During this session, scientists not versed in pharmacokinetics will be introduced to its key principles. We'll explore foundational PK topics such as clearance, exposures, and bioavailability, underscoring their significance in drug development. We'll give special attention to advanced concepts and their real-world applications. The program will span two sessions, addressing both theoretical and practical aspects.
Speakers' Bio:
Bonnie Wang is as an Associate Director in the clinical pharmacology division at Bristol-Myers Squibb (BMS). She serves as a clinical pharmacology lead in asset teams and governance discussions, offering crucial strategic guidance for designing clinical studies at various developmental phases. With over twenty years in the nonclinical drug development sector, her proficiency covers both small molecules and biologics, especially in the areas of DMPK and toxicology. Bonnie began her BMS tenure in 2004 after a notable four-year stint at Merck. Her educational background includes training in Molecular Biology and Nutrition. She has recently earned her MS in Pharmacometrics from the University of Maryland-Baltimore. Notably, she holds a diplomate certification from the American Board of Toxicology (DABT).
Jiangbo Tang is a Principal Scientist in the Department of Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis at Bristol-Myers Squibb (BMS). He leads regulated PK and immunogenicity bioanalytical development to support programs in CAR T, ADC, and antibody therapeutics. Prior to joining BMS, for several years he led a team at a CRO and provided regulated bioanalytical support for clinical programs. He also worked as a Staff Scientist in the QC Department at Regeneron, where he automated potency assays in support of stability, and lot release of drug products. Jiangbo received his PhD in Human Genetics from the University of Pittsburgh and completed his postdoc training at the University of Pennsylvania, where his published research in cancer biology and immunology has been widely cited with over 1,500 citations.
We are looking forward to receiving your support and feedback. Please feel free to reach out to [email protected] or [email protected] if you would like to be added to our mailing list.
Microsoft Teams meeting
Join on your computer, mobile app or room device
Click here to join the meeting
Meeting ID: 270 477 806 821
Passcode: aH3HVi
Download Teams | Join on the web
Or call in (audio only)
+1 908-409-1059,,384180506# United States, Elizabeth
(833) 733-5876,,384180506# United States (Toll-free)
Phone Conference ID: 384 180 506#
Find a local number | Reset PIN
------------------------------
Kelly Pham
Merck & Co
West Point PA
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------